Boston Scientific Buys Intelect

Xconomy Boston — 

Natick, MA-based medical devices giant Boston Scientific (NYSE:BSX) said today that it has acquired Intelect Medical, a developer of neuromodulation technologies for deep brain stimulation. Boston Scientific, which already owned an equity stake in Intelect, is buying the firm for about $60 million in cash. Intelect’s technology is expected to complement Boston Scientific’s existing deep brain stimulation offerings and to enable physicians to visualize stimulation fields in the brain in order to provide more precise therapy. Deep brain stimulation, for example, has been used to treat patients with Parkinson’s disease.